Satellitosis, a crosstalk between neurons, vascular structures and neoplastic cells in brain tumours; early manifestation of invasive behaviour by Civita, Prospero et al.
cancers
Review
Satellitosis, a Crosstalk between Neurons, Vascular
Structures and Neoplastic Cells in Brain Tumours;
Early Manifestation of Invasive Behaviour
Prospero Civita 1,2,* , Ortenzi Valerio 3 , Antonio Giuseppe Naccarato 3 , Mark Gumbleton 2
and Geoffrey J. Pilkington 1,2,4,*
1 Brain Tumour Research Centre, Institute of Biological and Biomedical Sciences (IBBS),
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK
2 School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences,
Cardiff University, Cardiff CF10 3NB, UK; gumbleton@cardiff.ac.uk
3 Department of Translational Research and New Technologies in Medicine and Surgery,
Pisa University Hospital, 56100 Pisa, Italy; valerio.ortenzi@ao-pisa.toscana.it (O.V.);
giuseppe.naccarato@med.unipi.it (A.G.N.)
4 Division of Neuroscience, Department of Basic and Clinical Neuroscience,
Institute of Psychiatry & Neurology, King’s College London, London SE5 9RX, UK
* Correspondence: CivitaP@cardiff.ac.uk (P.C.); geoff.pilkington@port.ac.uk (G.J.P.)
Received: 9 November 2020; Accepted: 4 December 2020; Published: 11 December 2020


Simple Summary: This article reviews the concept of cellular satellitosis as originally described
histologically by Santiago Ramón y Cajal in 1899 and Hans Joachim Scherer, more specifically in
the context of glioblastoma invasiveness, during the early part of the 20th century. With the advent
of new and emerging molecular technologies in the 21st century, the significance of both vascular
and neuronal satellitosis by neoplastic cells offers intriguing possibilities into further clarifying the
development, pathobiology and therapy of malignant glioma through closer investigation into the
nature of these histological hallmarks.
Abstract: The secondary structures of Scherer commonly known as perineuronal and perivascular
satellitosis have been identified as a histopathological hallmark of diffuse, invasive, high-grade
gliomas. They are recognised as perineuronal satellitosis when clusters of neoplastic glial cells
surround neurons cell bodies and perivascular satellitosis when such tumour cells surround blood
vessels infiltrating Virchow–Robin spaces. In this review, we provide an overview of emerging
knowledge regarding how interactions between neurons and glioma cells can modulate tumour
evolution and how neurons play a key role in glioma growth and progression, as well as the role of
perivascular satellitosis into mechanisms of glioma cells spread. At the same time, we review the
current knowledge about the role of perineuronal satellitosis and perivascular satellitosis within the
tumour microenvironment (TME), in order to highlight critical knowledge gaps in research space.
Keywords: brain tumour; satellitosis; glioblastoma; tumour heterogeneity; perineuronal satellitosis;
perivascular satellitosis; invasion
1. Introduction
One of the first histological descriptions of satellitosis in the nervous system was reported by
Santiago Ramón y Cajal in 1899, when he described aggregates of glial cells surrounding both the cell
body of neurons and its dendrites in healthy peripheral nervous tissue and only later in the 1930s this
phenomenon was termed with “perineuronal satellitosis” [1,2]. Further contributions came later by
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Brownson [1], Critchley, Andrew and Brain [3], Riese [4], showing such a numerical increase in satellite
cells in normal aged neurological specimens as well as in young normal brains [1,5]. This increase,
which does not necessarily indicate metabolic failure or even necrobiosis of neurons, suggests a
vitalizing-like event, a perfect example of the symbiotic relationship standing between neurons and
glial cells [2]. Most of the time, it indicates a condition that characterizes aged but essentially normal
brain specimens. The perineuronal satellitosis phenomenon has also been described in healthy tissues
of diverse brain regions such as cerebral cortex, hippocampus, basal ganglia and thalamus [1,2,6].
Although these aggregations of glial cells are frequently reported in physiological conditions, they are
more commonly known as a histological marker of various pathological conditions within the central
nervous system (CNS), for example, those associated with type I neurofibromatosis (NF1) [5], and they
have been mostly recognised as histopathological markers of diffuse neoplasms such as various grades
of astrocytoma and oligodendroglioma [6–10].
The first description of perineuronal and perivascular satellitosis in brain tumours was made
by Hans Joachim Scherer, a pioneer in the study of glioma growth patterns, in his pivotal paper
“Structural development in gliomas” [8]. After a careful revision of a certain number of glioblastomas
(GB), he designated as secondary structure any form of tumour growth depending on a pre-existing
tissue structure. He described thus seven types of secondary structures, plus an eighth type consisting
of an eventual combination of two or more of the former ones: (I) perineural growth (also named
neuronophagic growth), (II) surface growth, (III) perivascular growth, (IV) perifascicular growth,
(V) intrafascicular growth, (VI) interfibrillar growth, (VII) white or grey matter growth. Each of these
growth modalities, he observed, also had similar counterparts in specimens displaying findings of
reactive rather than neoplastic processes and could potentially be related to glioma histological types
and clinical prognosis.
Perineuronal growth, what we now define as perineuronal satellitosis (Figure 1A), is characterised
by growth of neoplastic cells around a neuron’s cell body and dendrites. Sometimes, this growth leads
to the replacement of neurons by groups of tumour cells (Figure 1B,C), a highly characteristic feature
which Scherer himself termed “neuronophagic growth” [8–10].
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Figure 1. (A–C) Histological observation of perineural satellitosis in glioblastoma. Haematoxylin and 
eosin stain show (A) Anaplastic, frankly malignant glial tumour cells (tc) induced neuronal apoptosis 
(B): only the picnotic remnant (Nr) of the neuron remains. In the end, (C) the vanishing neuron will 
Figure 1. (A–C) Histological observation of perineural satellitosis in glioblastoma. Haematoxylin and
eosin stain show (A) Anaplastic, frankly maligna t glial tumour cells (tc) induced euronal apoptosis
(B): only the picnotic remnant (Nr) of the neuron remains. In the end, (C) the vanishing neuron will be
completely replaced by tumour cells (ø). What normally occurs is that neoplastic cells surround the
neuronal cell body, which then results in neuronal cell death with intracellular degenerative change
and appearance of ‘ghost cells’ surrounded by the neoplastic cells in electron microscopy studies.
The neoplastic cells can also phagocytose the remains of the neurons. For detailed information refer
to [11,12]. Original images are collected at 400×magnification and relative region of interest (ROI) is
reported. The scale bars are 20 µm.
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Similar features were seen in Ethyl Nitrosourea (ENU)-induced gliomas in BD-IX rats where a
range of neuronal degenerative changes whereby at the most severe manifestation “ghost cells” or
dying neurons replaced normal neurons and these were surrounded by neoplastic glial cells [11,13].
Interestingly, both neuronal and perivascular satellitosis (Figure 2) have been demonstrated many years
ago by sequential electron microscopic examination of the subventricular zone (SVZ, also known
as the subependymal plate). In this rat model of glioma, pregnant rats were treated with a potent
neuro-carcinogen, Ethyl Nitrosourea, on the 16th day of gestation and the resultant offspring developed
glia neoplasms predominantly located adjacent to the lateral ventricles of the brain (a known ‘germinal’
zone). Thus the developmental genesis of such primary brain tumours could be followed and
manifested both peri-neuronal and perivascular satellitosis as early hallmarks of developing brain
tumours [7,12].
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lial ste cells (SEP) closely juxtaposed with a brain capillary (C) (right) and a neuronal cell body (Nr)
(upper left). ×10,800.
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,
.
ti [8], Scherer observed how this form of growth as an early manifestat on of tum ur spread
and probably one of the first pathways of neoplastic diffusion, yet tended to be present also in later
stages, highly infiltrative areas of tumours, and usually was easier to detect in cortical and striatum
grey matter than in white matter.
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Given these preliminary studies on the invasive pattern of glioma, he postulated that a complete
surgical excision of infiltrative glial neoplasms was technically impossible, thus explaining the high
and fast recurrence rates not only of GB but also of lower grade glial tumours: this concept could
be applied even at a time when hemispherectomies pioneered by Walter Dandy [14] were still being
practised as standard treatment for glial neoplasms, and recurrences were observed in the contralateral
hemisphere as early as six months postoperatively [15]. Despite these early speculations on the
functional significance of satellitosis, the phenomenon has received very little attention in more recent
years. In this review, we describe the biological crosstalk between glioma cells in satellitosis beyond
the histopathological importance of these patterns into neurological diseases, particularly into the
diagnosis and behaviour of pri ary brain tumours.
2. Satellitosis in Neurological Disease
2.1. Histological Characterisation of Perineuronal Satellitosis in Brain Tumours
The term satelli os usually refers t n increase in the number of cells encircling a neuron.
The term has been applied to both reactive and neoplastic processes. Sherer himself preferred the
term growth to define the neoplastic ones in order to avoid confusion [8]. In everyday practice
of neuropathology, neoplastic satellitosis (Figure 4A) is more commonly seen than reactive satellitosis
(Figure 4B), typically in association with diffuse astrocytic neoplasms [15] and easily found when
the tumour infiltrates the grey matter [16]. A common example of reactive process instead, can be
exemplified by neuron degeneration, where the satellite cells are usually represented by microglial cells
(Figure 4B) [17]. In order to recognise these patterns as microscopic features of neoplastic or reactive
pathological conditions and to distinguish perineuronal malignant satellitosis from reactive satellitosis
and microglial neuronophagia, the recognition of atypical nuclear morphology of infiltrating neoplastic
strocytes or even their glial nature could be difficult i the absence of immunohistochemical or
u trastructural analyses (Figure 1A). Also in ot r s ndary structures described by Scherer, such as
pe ivascular, subependymal, and subpial spread, s tellitosis mirrors the ability for the infiltrating
tumour cells to breach the gli limitans and enter the subarachnoid pace: even at gross observation,
typically during n urosurgeries for high g ade glioma resections, ne rosurgeons can easily recognize
mounds of tumour on the surface of the brain, and clearly see the presence of a subjacent tumour [18].
Among all CNS tumours, gliomas represent a typical primitive entity, and, in particular, gliomas are
frequently diffuse in nature [19]. Diffuse gliomas are distinctive due to their insidious pattern:
according to the fourth edition of the WHO Classification of Tumours of the CNS [20], they represent a
heterogeneous group of tumours characterised by a distinctive, infiltrative growth of surrounding
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neuropil and CNS structures. Based on both molecular and histopathological analysis, diffuse gliomas
are subdivided in astrocytic and oligodendroglial tumours (the diagnosis of mixed oligo-astrocytic
neoplasms being currently strongly discouraged by the WHO) and graded as low grade (WHO grade II)
or high grade (WHO grade III and IV). Providing an accurate distinction between the different diffuse
glioma types and malignancy grade has a significant impact on prognosis and therapeutic response [21].
Unfortunately, they all carry a fatal prognosis, even when treated with the most advanced protocols of
chemo- and radiotherapy combined with surgery [22,23].Cancers 2020, 12, x FOR PEER REVIEW 5 of 18 
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they did not reveal reliable or reproducible results. In this area instead, perineuronal satellitosis, 
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Figure 4. Histological observation and description ) perineuronal satellitosis in gliob astomas
(GB) and (B) perineuronal satellitosis in non-neoplastic brain damage condition. (A). Polymorphic,
markedly atypical glial tumour cells (tc) surrounding a neuron (Nr), which nevertheless shows only mild
sign of cellular, mostly hypoxic stress (darkened colour of nucleus and cytoplasm, focal vacuolisation,
chromatic dispersion); (B) Slightly atypical, non-neoplastic glial cells (g) are surrounding neurons
(Nr) with little changes, mostly due to hypoxic stress, in the collateral brain tissue of an active plaque
(patient with relapsing multiple sclerosis). The contact between the cell’s shapes, not only cytoplasmic
but also nucleus structure, creating nuclear membrane indentations (I). All images are shown at 400×
magnification and relative regions of interest (ROI) are reported. The scale bars are 50 µm.
Diffuse gliomas often appear to arise as subcortical white matter masses, subsequently diffusely
infiltrating the cortex and other grey matter areas. Diffusing lesions display variably atypical tumour
cells, organising themselves into secondary structures (predominantly perineuronal satellitosis in
more than 90% of cases) and causing the formation of regressive structures such as calcifications
and/or microcysts in surrounding tissue [24]. Recognition of extensive, diffuse infiltrative growth
in contiguous normal brain tissue structures is of great help in the diagnosis of diffuse glioma,
while at the same time explaining the predictability of tumour relapse associated with this kind of
neoplasm. Involvement of the cortical grey matter is a highly distinctive feature of diffuse tumours [25].
Within the grey matter, tumour cells are frequently found immediately adjac nt to neuronal cell bo ies,
where they are often referred to as satellite cells (satellite cells within t sensory ganglia of the peripheral
nervous system are present in large numb rs but represent Schwann cells) (Figure 1A) [1,2,6,24–27];
although immunohistochemical stains for myelin-associated glycoprotein (MAG) and for myelin basic
protein (MBP) have been used to reveal oligodendroglia cells, with varying success they did not reveal
reliable or reproducible results. In this area instead, perineuronal satellitosis, perivascular aggregations
of tumour cells (Figure 3), and subpial accumulations may be noted and provide valuable ancillary
clues to the diagnosis [21,28]. Microscopic examination shows that the tumour cells tend to invade
individually or in small groups in the neuropil, (the network of neuronal and glial cell processes in grey
and white matter). Only a few neoplasms such as metastatic lymphomas and occasionally metastases
from small cell lung carcinoma display such pattern of growth in the CNS [27]. Despite these early
findings related to neoplastic glial cell invasion and neur al satellitosis, the direct growth-promoting
effects of active neurons in the tumour microenvi onment and t mechanistic details in primary brain
tumours and other cancers has no been fully described [28]. Indeed, th ques ion whether neur nal
activity can promote glioma progression and eventually how efficient this promotion ay be has been
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investigated for many years without a true answer being found. Nowadays, an increasing body of
evidence suggests a possible role of neurons and neuronal activity in fuelling glioma growth and
neoplastic cell invasion [28–33].
2.2. Molecular Mechanisms Involved in Perineuronal Satellitosis Phenomena
Many studies investigated the role of non-neoplastic glial cells in GB growth and evolution [34–38],
proposing different mechanisms [32,33], which may even contribute to drug resistance [33].
However, increasing evidence supports the hypothesis that precursor glial cells, glial cells and
glioma cells may mutually benefit the close relationship with surrounding neurons [28]. Among glial
cells, astrocytes play a pivotal role in CNS tumours [34,35] as well as in physiological events
such as neurotransmission processes [36] water homeostasis, defense against oxidative/nitrosative
stress, energy storage, mitochondria biogenesis, scar formation, tissue repair via angiogenesis and
neurogenesis, synapse modulation by regulation of neurotransmitters and ions concentrations [37].
Astrocytic cells are actively involved in neurotransmitter recycling, clearance of extracellular potassium
ions, and in the propagation of Ca2+ waves [38]. The additional role of astrocytes as a source of
energetic fuel for neurons was originally proposed by Pellerin and co-workers (1994), who described an
activation of neurons with subsequent release of the neurotransmitter glutamate stimulating glycolysis
in nearby astrocytes: the lactate produced in this glycolytic burst is released back to neurons and pushes
neuronal metabolism further. The hypothesis has been termed the “Astrocyte-Neuron Lactate Shuttle
Hypothesis” (ANLSH): such a model does not exclude a direct neuronal glucose uptake. However,
it suggests that lactate produced by astrocytic glycolysis is the main metabolic fuel of glutamatergic
neurons during neurotransmission [39]. Although the hypothesis focuses on the mechanism by
which astrocytes may “talk” with neurons, we could pave the way for the hypothesis that neoplastic
astrocytes can interact with neurons in the same way. Pei et al. [40] reviewed the implication of
neurotransmitter molecules on glioma progression, underlining how glutamatergic and calcium (Ca+)
signaling exerts a positive feedback on glioma development by metabolic reprogramming, which
accelerates glioma growth.
Based on this earlier speculation Civita et al. [41] have analyzed the histological importance
of perineuronal satellitosis in human GB tissues. The authors claim to provide the first evidence of
single cell LCM RNA-seq of different regional compartments within “de novo” IDH1-wt GB samples,
particularly glial cells cuffing neurons and the neurons themselves reporting how satellite cells show
an up-regulation of genes related to integrins, specific metalloproteinases, aquaporins and cell division
control protein 42 homolog (CDC42) signalling, which are known to be involved in invasion and
glioma aggressiveness [42,43]. Notably, they report that the cells collected in satellitosis areas show an
overexpression of BRCA1, SPARCL1, MMP9 and MMP28 genes associated with GB malignancy [43–45].
Moreover, the over-representation of metabolic pathways (i.e., the TCA cycle) in both compartments
showed up not only an anchorage-dependent role of neuronal somata but a mutual exchange of
metabolic signals between cellular elements later identified as neoplastic cells [41]. However, the
limited number of samples, as well as the minimal quantity of tissue used, require further studies to
confirm these findings.
Zagzag D et al. in an elegant study [46] described how, under the stimulus of hypoxia and Vascular
Endothelial Growth Factor (VEGF), stromal cell-derived factor 1 alpha (SDF-1α), also known as C-X-C
motif chemokine 12 (CXCL12), expressed by neurons, blood vessels, subpial regions, and white matter
interacts with its own receptor expressed by glioma cells, inducing tumour cell migration in a chemokine
receptor type 4 (CXCR4) and 7 (CXCR7) anchorage-dependent manner [47]. This phenomenon was
one of the first descriptions of how the secondary structures of Scherer have a molecular basis and
should not be considered a casual feature of tumours.
In different pathological conditions such as stroke and brain ischemia, neural energy depletion is
accompanied by a massive release of glutamate [48]. It has been reported that glutamate and Alpha
ketoglutarate (α-KG) are key elements and fuel of glioma metabolism [49,50]. In the brain TME,
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the glutamate released by neurons acts in a migration-promoting way (i.e., as an ‘enhancer’) [51,52]
enhancing tumour cell spread within the brain parenchyma and implicated in brain tumour metastasis,
particularly breast to brain metastatic growth [29]; the N-methyl-D-aspartate (NMDA) receptor
signalling on breast metastatic cells may influence the uptake of glutamate from neurons and promote
tumour cell proliferation, thus proposing a rationale for brain metastatic growth. All together these
data support the idea that glutamate may have a key role in glioma progression as well: (I) by acting
as an excitotoxin, it clears space for tumour spread thereby promoting tumour growth, (II) by acting as
an “enhancer”, promoting cell motility and consequently promoting tumour invasion.
It is also known that glioma cells release glutamate by themselves [51] acting locally by leading
tumour growth [52,53], inducing excitotoxic activity [54], and causing cellular oedema [55]. High levels
of glutamate have been implicated in numerous seizure disorders [56], including glioma [57–60].
Studies conducted in both glioma patients and animal models have suggested that epilepsy activity
originating within the peritumoral edge, 1–2 mm away from the tumour mass, is related to invading
tumour cells surrounding neurons [61–63], showing how the epileptiform activity is more pronounced
in tumour-invaded neocortex. These phenomena explain why many patients’ seizures are an early
clinical sign and over 80% of glioma patients suffer seizures during the course of the disease [60,64].
Several ongoing and completed clinical trials are exploring the rationale for pharmacological targeting of
glutamate receptors and transporters to interrupt crosstalk in glutamate-mediated brain tumour growth.
More recent studies have also emphasised the role of synaptic input to brain tumour [65],
in particular of neuronal activity which in the adult brain induces neuroglial stem and progenitor cell
proliferation, and leads to the migration process via glutamatergic synapses [66], thus a similar process
could be adopted by glioma cells.
On a similar theme, Venkatesh et al. [67] in one of his extensive murine studies explored the
influence of neurons on glioma growth and demonstrated that certain cells, pyramidal neurons,
promote proliferation via the PI3K/mTOR pathway in adult and paediatric high grade glioma (HGG)
cell cultures by secreting neuroligin-3 (NLGN3) [67] and targeting NLGN3 could prove a basis for a
promising therapy in HGG [68]. The same group later showed that peritumoral neurons and glioma
cells directly interact through AMPA-receptors that drive tumour proliferation and invasion [69] by
facilitating oncogenic signalling cascades and cytoskeletal remodelling. Major findings are summarised
in Figure 5 and Table 1.
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Table 1. Summary of studies investigating the Perineuronal Satellitosis process within brain tumour in
in vivo and in vitro models along with the molecular mechanism proposed. Bold: is a summary title
which encompass different process.
Experimental Models Molecular Mechanism Proposed References
Human
Tissue sample and Animals
(First evidence) Histological visualisation
- “Neurophagic growth” substitution of tumour cell; [1–6,8,9,11,13]
Human
Tissue sample
Metabolic exchange and migration
- Upregulation of TCA cycle and transmembrane
transport of small molecules;
- CDC42 signalling and up-regulation BRCA1, SPARCL1,
MMP9, MMP28 and aquaporin (AQP1 and AQP4) as
well as EMT processes
[41]
Animals
(in vitro, in vivo)
Chemotactic attraction and migration
- VEGF, SDF1alpha, CXCR7
anchorage-dependent manner;
[46,47]
Animals
In vivo, in vitro
Patient derived GB cells
Metabolic exchange and spared within brain parenchyma
- Glutamate released by neurons acts: (I) “enhancer”;
(II) excitotoxin;
- NMDA receptor on cancer cells uptake glutamate
from neurons;
[29,51–53]
Human
In vivo; in vitro
Patient derived GB cells
Neuronal activity on glioma promotion
- Increase neuronal activity by Glutamatergic synaptic;
- Secretion of NLGN3 induce GB proliferation via
PI3K/mTOR;
- AMPA-receptors drive tumour proliferation;
[66,68–70]
Many strategies have been tested using in vivo models (summary Table 1) in order to study
the interactions between glioma cells and non-glioma brain cells, but lack of specific molecular
markers to clearly distinguish these two cell types and directly characterise their interactions in vivo
for short to long periods during glioma development have delayed knowledge on this interaction.
Nevertheless, evidence provided about the ‘back-and-forth’ of normal and malignant neural circuitry
could hold promise for targeted therapies to treat these devastating diseases.
2.3. Histological Characterisation of Perivascular Satellitosis in Brain Tumours
Tumour cells have long been known to connect with vascular structures, both from the tissues
they stem from and from infiltrated or metastasized ones. The first morphological evidence of this
interaction was reported at least as far back as 400 BC and 192 AD, respectively, by Hippocrates
and Galen [71]. It was John Hunter in 1787 that introduced the term angiogenesis and related it to
inflammatory processes [72]. While the first report of blood vessels apparently stemming within
tumours was reported by Rudolf Virchow in 1863 [73], when he showed that solid tumours have their
own blood supply, a few years later Thiersch (1865) and subsequently Goldmann (1908) provided more
precise descriptions of tumoral vessels as vascular neo-formations featuring high proliferation and both
chaotic and irregular growth [74,75], a description that may fit with the concept of tumour angiogenesis.
Early observations of perivascular patterns surrounding the Virchow–Robin spaces of pre-existing
brain vessels were reported by Scherer [8,9]. In his studies he reported that 35% of gliomas, both in
earlier and later disease stages, form cuffs of glial neoplastic cells surrounding capillaries and small
vessels of the brain. Later, he went on to recognise this process of “perivascular gliosis” as one of the
distinctive features of glial tumours [9]. Moreover, he pointed out how the organisation of glioma cells
tends to turn into the formation of cell cuffs around normal micro-vessels typically found in areas of
apparently normal brain parenchymal tissue at some distance from the original tumour mass, and he
underlined the precocity of the process in the biological history of the neoplasm [8]. This early finding
about perivascular satellitosis has inspired many groups over the years, which described the phenomenon
using a wide range of different terminologies, particularly “vessel co-option”. Even though researchers
use this term to describe the molecular mechanism where glioma cells reach and subsequently encircle
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vessels, the term perivascular satellitosis is still used by pathologists and is currently reported in textbooks
to teach the main histological features of vasculature in pathological conditions.
Perivascular satellitosis has been reviewed in many tumours by Kuczynski et al. [76] highlighting the
key histopathological traits associated with this process in cancer, while also clarifying the terminology
used for different processes.
In glioma, the term perivascular satellitosis is used to refer to a non-vasculogenic process whereby
blood vessels hijack glioma cells to migrate towards pre-existing vasculature (Figures 3 and 6) [77].
This feature has commonly been found in both high and low-grade glioma [15]. In high-grade
glioma cells entirely surround the blood brain barrier (BBB) capillaries (perivascular growth pattern),
modulating the function of pericytes and the properties of the BBB, while, in low grade glioma, vessels
are surrounded when the cancer cells infiltrate the brain parenchyma (diffuse infiltrating pattern) as
single cells in proximity to vessels.
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2.4. Molecular Mechanisms Involved in Perivascular Satellitosis Phenomenon
The mechanisms that trigger neoplastic “satellite” glial cells to migrate and invade are multiple
and interdependent [78].
Recent works [79,80] adopting new advanced intravital microscopy imaging technologies have
recorded patient-derived GB cell movement in mouse brain, showing by time-lapse how GB cells
closely interact with the microvasculature of BBB and they move along the pre-existing vasculature of
the brain. Here, neoplastic cells can travel several millimetres or even centimetres away from the main
tumour mass. Interestingly, during this invasion process the infiltrative cells, so-called guerilla cells,
protected from cytotoxic agents by an intact BBB, invade normal brain; in particular, it has been seen
that neoplastic cells adhere to vascular basal laminae, where mitogenic growth factors are sequestered
within the extracellular matrix components stimulating glioma cells to divide, suggesting that this
process that takes place around capillaries is a possible form of ‘pseudoinvasion’ [78].
A recent review by Seano et al. [81] discussed this phenomenon proposing two mechanisms:
(I) individual-cell co-option; and (II) collective-cell: vessel co-option mechanism [82]. The same
group also demonstrated the process behind the collective-vessel co-option that causes disruption
of the astrocyte: vascular coupling and blood-brain barrier (BBB) breach, with consequent blood
vessel leakage, abnormal vasculature (large lumen and tortuous architecture) and later inflammation.
While individual cell co-option is led by astrocyte-like GB cells (i.e., Olig2- and Wnt7-negative) via
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Olig2-Wnt7, a signalling axis [80] does not involve an inflammatory process and spread in association
with blood vessels; this later process is undetectable even with advanced imaging techniques [83].
Moreover, the authors raised the possibility that these mechanisms, although still unclear, might be
related to the failure of current anti-angiogenic treatments.
A number of mechanisms driven by diverse molecules have been proposed (summary Table 2) to
explain vascular satellitosis in mouse models. A few of these models were based on patient derived GB
cells [77,80,84–86] through in vitro cell culture, due to lack of relevant alternative models as well as the
high complexity of the GB microenvironment, particularly its marked tissue heterogeneity [87].
Table 2. Summary of studies investigating the Perivascular Satellitosis process within brain tumour in
in vivo and in vitro models along with the molecular mechanism proposed. Bold: is a summary title
which encompass different process.
Experimental Models Molecular Mechanism Proposed References
Human,
Animals in vivo
First histological description
Cuffs of glial neoplastic cells surrounding
pre-existing capillaries
[8,12]
Animals
(in vitro cells, in vivo)
GB cells interact with BBB:
Olig2+ oligodendrocyte precursor-like glioma cells
invade microvasculature by single-cell via Wnt7a/7b
[80]
Animals
(in vitro cells, in vivo)
Mechanism of Individual co-option and Collective
co-option:
Astrocyte-like GB cells interact with microvasculature via
Olig2-Wnt7a signalling axis
[80,81]
Animals
(In vivo cell lines)
Vascular recruitment
- Pro Angiogenic VEGF and anti-Angiogenetic
ANGPT1 balance
[88,89]
Human /Animal
(In vivo; in vitro Patient-derived-GB,
Tissue sample)
Chemotactic attraction and invasion
- Upregulation SDF-1α and CXCR4-receptor as well as
CXCR7 in GSCs with increase of OPT and CTSK;
- Bradykinin-bradykinin 2 receptors (B2R) interaction;
- endothelial IL-8 increased GSCs invasiveness and growth
- invasion and cooption depend on IRE1α
endoribonuclease activity
[90–96]
Human/Animals
In vivo; in vitro
GB cell/pericyte fusion-hybrids
Pericyte fusion-hybrids CDC42-dependent manner
promoting tumour diapedesis
[86]
Human
In vivo cellls; in vitro
Surrounding microvasculature and migration
Upregulation of Ephrin-B2 lead glioma cell migration
towards vessels
[85]
Previous studies from Holash [97] and Gale [88] aimed to understand the mechanism based
on the enrolment of cancer cells along pre-existing vessels, showing how tumour cell migration
towards perivascular sites is related to the expression of pro- and anti-angiogenic endothelial growth
factors, for example, angiopoietin-1 and 2 (ANGPT-1, ANGPT-2) and VEGF. Interestingly, they also
observed this process using rat mammary adenocarcinoma and then by injection of lung carcinoma cells
intravenously, which reach the brain parenchyma, cuffing normal brain blood vessels. This study was
later supported by Kusters [89] with further experiments using melanoma cells. Notably, he observed a
colonisation of melanoma cells within healthy brain parenchyma and the VEGF-engineered melanoma
cells hijacked pre-existing vessels without inducing any angiogenic process or sprouting of new vessels.
The deep interaction between glioma and vascular structures assures a continuous supply of
oxygen and nutrients essential for cell growth while glioma stem cells are exposed to a variety of
growth factors, chemokines, cytokines, and kinins.
Considering the role of the microenvironment on neural stem cells fate [98], Calabrese et al. [99]
have shown for the first time the presence of a vascular niche that regulates brain tumour stem cells.
This GSC niche is characterized by endothelial cells that interact closely with brain tumour cells
maintaining these cells in a stem-like state. Using mouse orthotopic model, they have observed that
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increasing the number of endothelial cells or blood vessels increases the fraction of self-renewing
cancer cells around the vascular structures, thus demonstrating the direct involvement of the vascular
structure into creating a favorable microenvironment for self-renewing of GSCs and tumour growth.
Although pioneering in the field of GCSs, the work from Calabrese et al. did not specify the type of
vasculature involved in these processes.
Later Hira et al. [91] claimed to demonstrate that the perivascular niches of GSCs involve arterioles,
not capillaries. By immunohistochemistry, they confirmed that CD133-positive and nestin-positive
GSC cells reside in hypoxic environments surrounding CD31-positive endothelial cells (ECs) and
smooth muscle actin (SMA)-positive smooth muscle cells of arterioles. Moreover, those GSCs express
not only a SDF-1/CXCR4 axis but also osteopontin (OPN) and cathepsin K (CTSK), showing how the
niche that surrounds arterioles resembles bone marrow hematopoietic stem cell (HSC) niche proteins
and recruits glioma stem cells by promotion of migration via CD44 and CXCR4 [91,92,100].
In pursuit of these themes, Zagzag D and his team [46,47] have shown, in different works,
how the up-regulation of (SDF)-1α and CXCR4-receptor as well as CXCR7 on glioma cells promotes
cell migration towards blood vessels through a saltatory process: this process includes periods of
immobility, during which glioma cell divisions take place near vascular branch points, suggesting that
the mitotic process and invasion are also triggered by local environmental cues.
Montana et al. [90] have shown how signals such as bradykinin promote the chemotactic attraction
and invasion of glioma cells that express bradykinin 2 receptors (B2R), proposing a B2R antagonist as a
future anti-invasive drug approach in glioma therapy.
More recent studies have also emphasized the role of GSCs in colonization of the perivascular
structure. In two distinct studies, co-culture of patient-derived GB and endothelial cells was
used to discover the chemotactic pathways activated by endothelial cells to stimulate GB cell
invasion. The authors showed that endothelial interleukin-8 (IL-8) increased GSCs invasiveness
and growth [94,101]. A clear example of crosstalk between glioma cells and components of BBB was
also reported by Caspani et al. [83], which showed that close interaction between tumour cells and
pericytes gives rise to GB cell/pericyte fusion-hybrids in a CDC42-dependent manner and promotes
tumour diapedesis. Cell-to-cell communication between glioma cells and perivascular cells has been
documented by use of intravital imaging in a murine model of GB [85]. The authors showed how
the endothelial cells, via overexpression of Ephrin-B2, lead glioma cells to surround vessels, thus the
downregulation of this process may improve patient survival.
At least five different neovascularisation processes have been identified in GB: (i) vascular
co-option, (ii) angiogenesis, (iii) vasculogenesis, (iv) vascular mimicry, and (v) glioblastoma endothelial
cell trans-differentiation [102]; the underlying biological mechanisms and classification of human
tumours based on these particular processes are still unclear. All major findings and molecular
mechanisms are summarized in Figure 7 and Table 2.
Diffuse invasion of the brain parenchyma along pre-existing blood vessels, could be a leading
cause of therapeutic resistance, but the mechanisms—in particular those of cell adhesion to extracellular
matrix proteins and mitogen-stimulated neoplastic cell division—remain unclear in GB, while in other
cancers this knowledge has revolutionized prognosis [103].
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3. Concluding Remarks
Up to date, satellitosis has been variously discussed as an independent entity in brain tumours:
this misconception leads to underestimating the significance of this histological feature, and prevents us
from completely understanding its importance in disease progression and its potentially crucial role in
the discovery of novel therapeutic strategies. The findings shown above report the current knowledge
regarding the particular histo-morphological entities of perineuronal satellitosis and perivascular
satellitosis: neither of them are randomly occurring formations, but indeed demonstrate that glioma
cells have specific forms of tropism for particular brain structures. Unfortunately, our understanding of
them is hampered by the limits of our experimental models, since neither patient-derived cell lines nor
rodent cell lines can currently give us a fully reliable model of how tumour cell invasiveness towards
any surrounding/stromal tissue happens and what it finally means [104]: this problem remains a
huge obstacle, creating significant difficulties in the development of effective therapies against such
aggressive neoplasms as diffuse gliomas.
Recent developments in advanced MR and PET scanning have improved CNS imaging, up to
the point that now we can collect specific information within brain TME compartments [105–107].
Nevertheless, a careful histo-morphological evaluation of tumour tissue by pathologists is still of
fundamental importance, and features such as Scherer’s secondary structures are still a valuable clue
into the diagnosis of diffuse, possibly high-grade gliomas.
New, highly sophisticated in vitro models, stemming from either patient-derived tumour cells or
pluripotent stem cells, could provide a scalable in vitro model to study diffuse gliomas [108,109] or
metastatic brain cancer [110], although both with such limitations due to the lack of stromal component
including vasculature. An effective matching of these models with a detailed pathological analysis,
based on the combination of histomorphology and molecular parameters, should be employed to scan
through glial neoplasms genetics and metabolic heterogeneity, in order to better understand TME
complexity and eventually assess the predicted efficacy of targeted therapies [111].
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